Patents by Inventor Michael Corbo

Michael Corbo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating Coronavirus Disease 2019
    Publication number: 20230149407
    Abstract: The present invention is related to the discovery of new methods for treating the pathologic inflammatory response associated with patients infected with SARS-CoV-2 comprising administering orally to the patient in need of such treatment a therapeutically effective amount of a JAK inhibitor, a JAK/TYK inhibitor, or an IRAK4 inhibitor, or a combination thereof.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 18, 2023
    Applicant: Pfizer Inc.
    Inventors: Michael Corbo, Spencer Ian Danto, Tamas Andras Koncz, Elena Peeva, Hernan Valdez, V, Michael Steven Vincent, Cara Margaret May Williams
  • Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
    Patent number: 9012408
    Abstract: The invention relates to methods and compositions for treating undifferentiated arthritis (UA) and/or preventing the development of rheumatoid arthritis (RA) in subjects with UA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: April 21, 2015
    Assignee: Bristol-Myers Squibb Company
    Inventors: George Vratsanos, Jean-Claude Becker, Michael Corbo
  • Method for retarding progression to definite rheumatoid arthritis in subjects with undifferentiated arthritis
    Patent number: 8435952
    Abstract: The invention relates to methods and compositions for treating undifferentiated arthritis (UA) and/or preventing the development of rheumatoid arthritis (RA) in subjects with UA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: May 7, 2013
    Inventors: George Vratsanos, Jean-Claude Becker, Michael Corbo
  • METHOD OF PREVENTING THE DEVELOPMENT OF RHEUMATOID ARTHRITIS IN SUBJECTS WITH UNDIFFERENTIATED ARTHRITIS
    Publication number: 20110142835
    Abstract: The invention relates to methods and compositions for treating undifferentiated arthritis (UA) and/or preventing the development of rheumatoid arthritis (RA) in subjects with UA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule.
    Type: Application
    Filed: February 10, 2011
    Publication date: June 16, 2011
    Inventors: George Vratsanos, Jean-Claude Becker, Michael Corbo
  • Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
    Patent number: 7915222
    Abstract: The invention relates to methods and compositions for treating undifferentiated arthritis (UA) and/or preventing the development of rheumatoid arthritis (RA) in subjects with UA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule.
    Type: Grant
    Filed: May 1, 2009
    Date of Patent: March 29, 2011
    Assignee: Bristol-Myers Squibb Company
    Inventors: George Vratsanos, Jean-Claude Becker, Michael Corbo
  • Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
    Publication number: 20090280119
    Abstract: The invention relates to methods and compositions for treating undifferentiated arthritis (UA) and/or preventing the development of rheumatoid arthritis (RA) in subjects with UA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule.
    Type: Application
    Filed: May 1, 2009
    Publication date: November 12, 2009
    Inventors: George Vratsanos, Jean-Claude Becker, Michael Corbo
  • Analgesic/Antipyretic Compositions for Enhanced Absorption
    Publication number: 20070298096
    Abstract: The onset of activity of a first analgesic/antipyretic composition containing an analgesic/antipyretic effective amount of acetaminophen, caffeine and, optionally, aspirin is shortened by incorporating in the first composition an onset of analgesic/antipyretic activity shortening amount of at least one alkaline agent whereby a second composition is produced. The second composition being bioequivalent to the first composition but having a shorter onset of analgesic/antipyretic activity than the first composition.
    Type: Application
    Filed: October 26, 2005
    Publication date: December 27, 2007
    Inventors: Rong Liu, Michael Corbo, Jatin Desai, Gerard Frunzi, Xiaohong Qi, Candice Choi, Rahul Gandhi, Atef Boulos
  • Taste masking composition
    Publication number: 20070122475
    Abstract: A composition for delivery of a medicament that has a bitter taste and/or causes throat catch is provided. The composition contains Carbomer 934, Carbomer 971, Carbomer 974, PEG-5M or a mixture thereof in an amount sufficient to mask the bitter taste of the medicament and/or throat catch.
    Type: Application
    Filed: January 24, 2007
    Publication date: May 31, 2007
    Inventors: Michael Corbo, John Migton, Mahesh Patell
  • Taste masking coating composition
    Patent number: 6663893
    Abstract: There is provided a coating composition that masks the undesirable taste of a pharmaceutically active ingredient, i.e. drug or medicine, that is taken orally. The coating composition is comprised of dimethylaminoethyl methacrylate and neutral methacrylic acid ester, a cellulose ester polymer, and an alkaline modifier.
    Type: Grant
    Filed: February 5, 2002
    Date of Patent: December 16, 2003
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Michael Corbo, Jatin Desai, Mahesh Patell, Ronald Warrick
  • Process for coating stents and other medical devices using super-critical carbon dioxide
    Patent number: 6627246
    Abstract: This invention provides an improved process for coating medical and surgical devices and the like using super-critical fluids.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: September 30, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Deepak B. Mehta, Michael Corbo
  • Taste masking coating composition
    Patent number: 6551617
    Abstract: There is provided a coating composition that masks the undesirable taste of a pharmaceutically active ingredient, i.e. drug or medicine, that is consumed orally. The coating composition has polyvinyl acetate, and a dimethylaminoethyl methacrylate and neutral methacrylic acid ester. Optionally, an alkaline modifier may be included in the coating composition to enhance release of the active ingredient.
    Type: Grant
    Filed: April 20, 2000
    Date of Patent: April 22, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Michael Corbo, Jatin Desai, Mahesh Patell, Ronald Warrick
  • Taste masking composition
    Publication number: 20030039687
    Abstract: A composition for delivery of a medicament that has a bitter taste and/or causes throat catch is provided. The composition contains Carbomer 934, Carbomer 971, Carbomer 974, PEG-5M or a mixture thereof in an amount sufficient to mask the bitter taste of the medicament and/or throat catch.
    Type: Application
    Filed: August 1, 2002
    Publication date: February 27, 2003
    Inventors: Michael Corbo, John Migton, Mahesh Patell
  • Taste masking coating composition
    Publication number: 20020197317
    Abstract: There is provided a coating composition that masks the undesirable taste of a pharmaceutically active ingredient, i.e. drug or medicine, that is taken orally. The coating composition is comprised of dimethylaminoethyl methacrylate and neutral methacrylic acid ester, a cellulose ester polymer, and an alkaline modifier.
    Type: Application
    Filed: February 5, 2002
    Publication date: December 26, 2002
    Inventors: Michael Corbo, Jatin Desai, Mahesh Patell, Ronald Warrick
  • Process for coating stents and other medical devices using super-critical carbon dioxide
    Publication number: 20020051845
    Abstract: This invention provides an improved process for coating medical and surgical devices and the like using super-critical fluids.
    Type: Application
    Filed: April 17, 2001
    Publication date: May 2, 2002
    Inventors: Deepak B. Mehta, Michael Corbo
  • Transdermal dosage unit, system and process
    Patent number: 5045319
    Abstract: Provided by this invention are novel transdermal dosage units for administering cardiovascular pharmaceuticals, whereby enhanced absorption with essentially zero-order kinetics is obtained. Also provided is a process for administration of cardiovascular pharmaceuticals by use of said dosage units.
    Type: Grant
    Filed: October 18, 1988
    Date of Patent: September 3, 1991
    Assignee: Rutgers, The State University of New Jersey
    Inventors: Yie W. Chien, Michael Corbo